Sumatriptan Tablet
Product Images NDC 68071-3802

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sumatriptan (NDC 68071-3802). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3802 9)

This text appears to be a product label for Sumatriptan, a medication used for migraine relief. The label contains important information such as dosage (50mg), lot number, National Drug Code (NDC), manufacturer NDC, expiration date, and a warning to keep out of reach of children. It also provides contact information for reporting side effects and storage instructions at a controlled temperature of 68-77°F.*

FDA Label Image

Figure 1. Estimated Probability Of Achieving Initial Headache Response Within 4 Hours Of Treatment In Pooled Trials 1, 2, And 3a (Sumatriptan Fig1)

This is a data table showing percentages, estimated probability of response, and time in minutes from initial dose. It appears to be related to some sort of analysis or study with different metrics being measured.*

FDA Label Image

Figure 2. The Estimated Probability Of Patients Taking A Second Dose Of Sumatriptan Tablets Or Other Medication To Treat Migraine Over The 24 Hours Following The Initial Dose Of Study Treatment In Poo (Sumatriptan Fig2)

FDA Label Image

Chemical Structure (Sumatriptan Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.